dpb-pharma-aboutus

Kinvan Private Ltd – Kinvan

Kinvan, a proud venture of the DPB Group, stands as India’s leading manufacturing facility of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)

Kinvan will cater to almost half of the India’s consumption requirements and more than 95 % of raw material required for this KSM will be consumed from domestic sources making it extremely self-reliant

Products List
Key features:
Accredited by the Government of India under the Production Linked Incentive (PLI) Scheme, Kinvan serves as a benchmark in the industry.
It is a two-phase project, with Phase 1 focusing on the setup of KSMs like Potassium Clav and Phase 2 targeting KSMs like 6 APA and PenG.
With a total investment of 100 Million USD, the first phase of the project was turned around in record time of 18 months with 65 Mn USD.
First unit for potassium clavulanate in India and 8th in the world.

Kinvan Highlights

Infrastructure

Capacity of 400 MTs annually:
Serving a global market of 2500 MTs and Indian market of 1400 MTs p.a.
Built over 50 acres, Kinvan generates direct employment for 500 people (1500+ indirect jobs).

Facilities

Two multi-purpose plants:
8 fermenters of 250 KL each.
Filtration systems from HAR Italia.
Extraction system Westfalia GEA Germany.

Operational Strength

Green technology used; fossil fuel consumption cut down by 70%.
Highly efficient solvent recovery plan.

Commitment to Excellence

Zero Liquid Discharge (ZLD):
Kinvan houses a 4 MLD Effluent Treatment Plant, earning it a ZLD status. Net 0 emission company by 2033.

Gallery

Kinvan Private Ltd – Glimpse of the plant to be commissioned in November 2023

Call us for Queries

022-40628300
Contact Us
Pioneering excellence and accessibility in
pharma manufacturing

DPB Group stands as a pillar in the pharmaceutical manufacturing landscape of India, shaping the industry with our innovative practices and consistent quality

pioneering-pharma